Addison Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Buy
1,387
+7
+0.5% +$7.1K 0.28% 73
2025
Q4
$1.48M Buy
1,380
+47
+4% +$44.9K 0.33% 63
2025
Q3
$1.02M Buy
1,333
+192
+17% +$143K 0.24% 77
2025
Q2
$889K Sell
1,141
-26
-2% -$20.2K 0.22% 79
2025
Q1
$964K Buy
1,167
+215
+23% +$179K 0.26% 67
2024
Q4
$735K Sell
952
-14
-1% -$11.6K 0.2% 80
2024
Q3
$856K Buy
966
+30
+3% +$27K 0.24% 75
2024
Q2
$847K Buy
936
+46
+5% +$36.8K 0.27% 69
2024
Q1
$692K Buy
890
+237
+36% +$169K 0.24% 78
2023
Q4
$381K Hold
653
0.15% 112
2023
Q3
$351K Buy
653
+3
+0.5% +$1.55K 0.16% 104
2023
Q2
$305K Hold
650
0.15% 115
2023
Q1
$223K Sell
650
-17
-3% -$5.73K 0.13% 129
2022
Q4
$244K Buy
667
+9
+1% +$3.19K 0.15% 113
2022
Q3
$213K Hold
658
0.13% 108
2022
Q2
$213K Buy
658
+1
+0.2% +$300 0.13% 119
2022
Q1
$188K Buy
657
+2
+0.3% +$515 0.1% 145
2021
Q4
$181K Buy
655
+5
+0.8% +$1.27K 0.11% 126
2021
Q3
$150K Hold
650
0.12% 101
2021
Q2
$149K Buy
+650
New +$131K 0.12% 103
2020
Q4
$110K Buy
+650
New +$97K 0.11% 118

Other funds holding LLY

Addison Advisors's LLY Position: Q1 2026 in Review

Addison Advisors increased its Eli Lilly (LLY) stake by 0.51% in Q1 2026, buying an estimated $7.1K and bringing the position to 1,387 shares worth $1.28M. The position accounts for 0.28% of the portfolio, ranked #73.

Addison Advisors first reported a position in LLY in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.48M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Addison Advisors held 1,387 shares of Eli Lilly worth $1.28M as of Q1 2026.
  • Addison Advisors bought 7 Eli Lilly shares in Q1 2026, an estimated $7.1K.
  • Eli Lilly made up 0.28% of Addison Advisors's portfolio in Q1 2026, its #73 holding.
  • Addison Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 21 quarters since.
  • Addison Advisors's Eli Lilly position peaked at $1.48M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.